The Economic and Social Council met on 15th and 16th July, during its 2014 Session to discuss item 7 on Social and Human Rights Questions. Item 17(d) focused on narcotic drugs (A/69/87–E/2014/80, E/2013/28/Add.1, E/2014/28 and E/INCB/2013/1). A summary of the discussions is available below. Introductory statements President INCB At a time when discussions and actions …
International Narcotics Control Board (INCB)
Side event – Coordinated efforts to increase access to controlled drugs for medical purposes
Mr. David Lewis, Australian Permanent Mission. Appreciates efforts of Dr. Gerra. Panama’s efforts in WHO EB resolution. Drawing upon CND resolution on which Australia has led for relief of pain and suffering. High priority on access to medical opioids for pain relief and palliative care. Moral obligation to work for better access. Guaranteeing access was …
CND Plenary Day 3 – Scheduling of Dronabinol, methodrone and Ketamine
Scheduling of Dronabinol, methodrone and Ketamine INCB has provided a report on APAAN and suggested it should be included on table 1 of the schedule of the 1988 convention. The commission needs to decide whether it will do this or take other action. Mephedrone is up for scheduling also to support member states to take …
Raymond Yans Civil Society Dialogue organized by VNGOC
INCB meeting with Raymond Yans. Introduction by Raymond Yans on INCB work. Very proforma. Michel Perron gave format of the meeting. He will read pre-submitted questions. Question on prevention. Yans: Role of INCB is first of all to monitor the implementation of the conventions and in doing so look at all the scope of drug …
NGO Dialogue with INCB President Raymond Yans
We tend to meet with government agencies, but also NGOs. Those we meet are advised by us. NGOs are an important link for us. They are important for drug prevention, treatment and rehabilitation. Given the changes taking place in Uruguay, USA and Europe around drug policy, how can the INCB react to these changes in …
CND Plenary Day 1 – Item D: Allowing the availability of controlled drugs for medical and scientific purposes
Raymond Yans, INCB. Ensuring the availability of controlled drugs for medical and scientific purposes has always been a major goal of the treaties. IN 2010, the INCB issued a special report on the issue to provide a global overview of consumption and availability and impediments and recommendations to improve availability. Since then, the international community …